For women with HER2+ breast cancer, TNJ may suppress tumor growth to allow additional time for surgical or other therapeutic interventions and may enhance the chemotherapy response, as has been reported for noni in rodent models for other types of cancer [41, 53]. The gene discussed is ERBB2; the disease is breast cancer.